Dr. Hillengass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elm and Carlton Streets
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-2293- Is this information wrong?
Summary
- Dr. Jens Hillengass is a hematologist in Buffalo, NY and is affiliated with Roswell Park Comprehensive Cancer Center. He received his medical degree from University of Heidelberg Faculty of Medicine and has been in practice 15 years. He specializes in hematologic oncology and is experienced in multiple myeloma, amyloidosis, stem cell transplantation, hematologic oncology and hematologic malignancies.
Education & Training
University of Heidelberg Faculty of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2018 - 2025
Clinical Trials
- Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma Start of enrollment: 2019 Dec 17
- Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma Start of enrollment: 2020 Aug 24
- Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant Start of enrollment: 2024 Apr 30
- Join now to see all
Publications & Presentations
PubMed
- Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population.Tang, L., Lesokhin, A., Landgren, O., Usmani, S., Moysich, K., Shah, U., Joseph, J., McCann, S., Hillengass, J.> ;Blood Advances. 2024 Feb 13
- Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Kumar, S., Callander, N., Adekola, K., Anderson, L., Baljevic, M., Baz, R., Campagnaro, E., Castillo, J., Costello, C., D'Angelo, C., Derman, B., Devarakonda, S., Else...> ;Journal of the National Comprehensive Cancer Network. 2024 Jan 1
- Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients.Elias K Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Sonja Zweegman, Marc S Raab, Markus Munder, Lucia Pantani, Katia Mancuso, Peter Brossart, Meral Beksac, I...> ;Leukemia. 2024 Mar 1
- Join now to see all
Press Mentions
Harpoon Therapeutics : ASH2022 Interim ClinicalDecember 12th, 2022- Roswell Park Sequencing Study Unlocks Mystery of Multiple MyelomaFebruary 14th, 2022
- Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance MechanismsDecember 7th, 2020
- Join now to see all
Committees
- Vice-Chair for Imaging, Myeloma Committee, Alliance for Clinical Trials 2022 - Present
- Co-Chair for Imaging and Bone Disease, International Myeloma Working Group 2020 - Present
- Member Amyloidosis, Multiple Myeloma, Waldenström Macroglobulinemia, NCCN 2018 - Present
Other Languages
- German
Hospital Affiliations
Roswell Park Comprehensive Cancer CenterBuffalo, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
